🟢 Inovio Pharmaceuticals is trading 5.7% up today as biotech stocks and broader U.S. markets rebound

Inovio Pharmaceuticals is trading 5.65% up now at $1.21 as biotechnology stocks and broader U.S. markets rebound on September 17, 2026.

• No new company-specific announcement or catalyst was identified; the move appears primarily linked to stronger sector sentiment.
• Biotech ETF performance improved as risk appetite returned after the Federal Reserve decision.
• Inovio Pharmaceuticals’ next major known catalyst is the October 30 FDA decision for INO-3107.